logo
ProjectForthcoming

Integrated Mapping of Proteomic And struCtural Transitions in Cells

Sector: Commercial • Location: Poland, Germany, Spain, Denmark, Sweden

Source: EU Funding & Tenders Portal

This project establishes an integrated capacity-building framework for analysing drug-induced changes in cellular organisation by combining quantitative proteomics, post-translational modification (PTM) profiling, single-cell analysis and in situ structural biology. Its main objective is to institutionalise at the Małopolska Centre of Biotechnology (MCB) a coherent and reproducible workflow that l

Status
Prospective
Sector
Commercial, Chemical (Industrial), Manufacturing (Industrial), Residential
Location
Poland, Germany, Spain, Denmark, Sweden
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Integrated Mapping of Proteomic And struCtural Transitions in Cells

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Integrated Mapping of Proteomic And struCtural Transitions in Cells” is an infrastructure initiative in the Commercial sector, located in Poland, Germany, Spain, Denmark, Sweden. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

This project establishes an integrated capacity-building framework for analysing drug-induced changes in cellular organisation by combining quantitative proteomics, post-translational modification (PTM) profiling, single-cell analysis and in situ structural biology. Its main objective is to institutionalise at the Małopolska Centre of Biotechnology (MCB) a coherent and reproducible workflow that links biochemical measurements with spatial and structural interpretation, addressing the current fragmentation of expertise. Drug exposure is used as a controlled and transferable perturbation model relevant to metabolic and civilisation-related diseases. Rather than focusing on drug discovery, the project emphasises methodological training and mechanistic understanding of how chemical perturbations reshape protein abundance, PTM states, molecular interactions and cellular architecture, providing a robust testbed for integrated, multiscale analysis. Through collaboration with leading European partners, the project enables structured transfer of expertise in advanced proteomics, PTM-centric analysis, single-cell methodologies, visual proteomics, cellular cryo-electron tomography, high-resolution structural biology and computational modelling. Knowledge transfer is embedded through joint measurement campaigns, staff exchanges, hands-on training and shared benchmarking. A key enabling component is the establishment and professionalisation of a Grant Office at MCB. By strengthening administrative competences and creating a durable interface between researchers and research support, the project enhances MCB’s ability to participate in competitive European funding schemes and supports long-term integration into the European Research Area. By the end of the project, MCB will operate an integrated, PTM-aware and structure-resolved analytical platform supported by a strengthened institutional support environment.

Location

Country

Poland, Germany, Spain, Denmark, Sweden

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Commercial, Chemical (Industrial), Manufacturing (Industrial), Residential

Article published date

2026-11-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project